Kejun Nan

3.0k total citations
60 papers, 1.6k citations indexed

About

Kejun Nan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Kejun Nan has authored 60 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 30 papers in Cancer Research and 25 papers in Oncology. Recurrent topics in Kejun Nan's work include Cancer-related molecular mechanisms research (16 papers), MicroRNA in disease regulation (11 papers) and Cancer-related Molecular Pathways (7 papers). Kejun Nan is often cited by papers focused on Cancer-related molecular mechanisms research (16 papers), MicroRNA in disease regulation (11 papers) and Cancer-related Molecular Pathways (7 papers). Kejun Nan collaborates with scholars based in China, United States and Taiwan. Kejun Nan's co-authors include Tao Tian, Hui Guo, Zhiping Ruan, Shuhong Zhao, Qiuping Liu, Mo‐qi Lv, Dang‐xia Zhou, Lili Jiang, Xuan Liang and Xiao Fu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kejun Nan

59 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kejun Nan China 24 1.1k 829 435 230 175 60 1.6k
Hung‐Wei Pan Taiwan 21 877 0.8× 524 0.6× 276 0.6× 166 0.7× 179 1.0× 28 1.3k
Tae Matsumura Japan 15 1.1k 1.0× 900 1.1× 290 0.7× 120 0.5× 174 1.0× 66 1.6k
Daimin Xiang China 17 1.2k 1.1× 764 0.9× 301 0.7× 92 0.4× 200 1.1× 28 1.6k
Shanzhou� Huang China 18 915 0.9× 591 0.7× 375 0.9× 298 1.3× 178 1.0× 69 1.4k
Renan Jin China 17 703 0.7× 463 0.6× 274 0.6× 195 0.8× 156 0.9× 34 1.2k
Le‐Qun Li China 20 685 0.6× 598 0.7× 542 1.2× 197 0.9× 229 1.3× 63 1.5k
Cheol-Keun Park South Korea 23 682 0.6× 441 0.5× 371 0.9× 200 0.9× 212 1.2× 48 1.3k
Miriam Farina Italy 10 837 0.8× 393 0.5× 332 0.8× 168 0.7× 209 1.2× 20 1.5k
Lui Ng Hong Kong 19 805 0.8× 651 0.8× 676 1.6× 151 0.7× 89 0.5× 45 1.6k
Chang Han United States 19 983 0.9× 943 1.1× 837 1.9× 390 1.7× 337 1.9× 40 2.0k

Countries citing papers authored by Kejun Nan

Since Specialization
Citations

This map shows the geographic impact of Kejun Nan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kejun Nan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kejun Nan more than expected).

Fields of papers citing papers by Kejun Nan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kejun Nan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kejun Nan. The network helps show where Kejun Nan may publish in the future.

Co-authorship network of co-authors of Kejun Nan

This figure shows the co-authorship network connecting the top 25 collaborators of Kejun Nan. A scholar is included among the top collaborators of Kejun Nan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kejun Nan. Kejun Nan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Du, Lan, Jing Li, Tao Tian, et al.. (2019). Clinicopathological and prognostic significance of pretreatment thrombocytosis in patients with endometrial cancer: a meta-analysis.. SHILAP Revista de lepidopterología. 11. 4283–4295. 6 indexed citations
3.
Li, Wenyuan, Qing Li, Jing Li, et al.. (2018). P57‐mediated autophagy promotes the efficacy of EGFR inhibitors in hepatocellular carcinoma. Liver International. 39(1). 147–157. 17 indexed citations
4.
Wang, Yu, Jing Li, François X. Claret, et al.. (2017). Autophagy in the “inflammation-carcinogenesis” pathway of liver and HCC immunotherapy. Cancer Letters. 411. 82–89. 58 indexed citations
5.
Shen, Yuan, Hui Guo, Tao Wu, et al.. (2017). Lower Education and Household Income Contribute to Advanced Disease, Less Treatment Received and Poorer Prognosis in Patients with Hepatocellular Carcinoma. Journal of Cancer. 8(15). 3070–3077. 21 indexed citations
6.
Li, Qing, Tao Wu, Jing Li, et al.. (2017). Angiogenesis inhibitors for the treatment of small cell lung cancer (SCLC). Medicine. 96(13). e6412–e6412. 15 indexed citations
7.
Ma, Jiequn, Xiao Fu, Lili Jiang, et al.. (2016). Pleiotrophin as a potential biomarker in breast cancer patients. Clinica Chimica Acta. 466. 6–12. 19 indexed citations
8.
Liu, Zhiyan, Tao Wu, Qing Li, et al.. (2016). Notch Signaling Components. Medicine. 95(20). e3715–e3715. 22 indexed citations
9.
Yang, Chengcheng, Jiequn Ma, Lili Jiang, et al.. (2015). High Skp2/Low p57Kip2 Expression is Associated with Poor Prognosis in Human Breast Carcinoma. Breast Cancer Basic and Clinical Research. 9s1(Suppl 1). BCBCR.S30101–BCBCR.S30101. 27 indexed citations
10.
Wang, Mincong, Chunli Li, Jie Cui, et al.. (2015). BMI-1, a promising therapeutic target for human cancer. Oncology Letters. 10(2). 583–588. 71 indexed citations
11.
Tu, Honglei, Yan Lin, Jie Ding, et al.. (2014). Oxidative Stress Upregulates PDCD4 Expression in Patients with Gastric Cancer via miR-21. Current Pharmaceutical Design. 20(11). 1917–1923. 49 indexed citations
12.
Hu, Tinghua, Shuo Yu, Hui Guo, et al.. (2014). [CXCR4 and Nrf2 expressions in non-small cell lung cancer and their clinical implications].. PubMed. 34(2). 153–8. 5 indexed citations
13.
Wang, Wenjuan, Yu Yao, Lili Jiang, et al.. (2013). Knockdown of Lymphoid Enhancer factor 1 Inhibits Colon Cancer Progression In Vitro and In Vivo. PLoS ONE. 8(10). e76596–e76596. 44 indexed citations
14.
Wang, Guoqing, et al.. (2013). Associations between Fas/FasL polymorphisms and susceptibility to cervical cancer: a meta-analysis. Tumor Biology. 35(5). 4107–4112. 3 indexed citations
15.
Ruan, Zhiping, Rui Xu, Tao Tian, et al.. (2012). Bmi1 knockdown inhibits hepatocarcinogenesis. International Journal of Oncology. 42(1). 261–268. 12 indexed citations
16.
Ruan, Zhiping, Rui Xu, Yi Lv, et al.. (2012). PTEN Enhances the Sensitivity of Human Hepatocellular Carcinoma Cells to Sorafenib. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 20(2). 113–121. 18 indexed citations
17.
Guo, Hui, Yifei Lv, Tao Tian, et al.. (2011). Downregulation of p57 accelerates the growth and invasion of hepatocellular carcinoma. Carcinogenesis. 32(12). 1897–1904. 33 indexed citations
18.
Nan, Kejun. (2005). Expression of p57kip2and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma. World Journal of Gastroenterology. 11(8). 1237–1237. 21 indexed citations
19.
Nan, Kejun. (2005). Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis. World Journal of Gastroenterology. 11(2). 228–228. 10 indexed citations
20.
Nan, Kejun. (2004). Expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27Kip1in hepatocellular carcinoma. World Journal of Gastroenterology. 10(10). 1425–1425. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hung‐Wei Pan Breakdown of academic impact, for papers by Tae Matsumura Breakdown of academic impact, for papers by Daimin Xiang Breakdown of academic impact, for papers by Shanzhou� Huang Breakdown of academic impact, for papers by Renan Jin Breakdown of academic impact, for papers by Le‐Qun Li Breakdown of academic impact, for papers by Cheol-Keun Park Breakdown of academic impact, for papers by Miriam Farina Breakdown of academic impact, for papers by Lui Ng Breakdown of academic impact, for papers by Chang Han
Rankless by CCL
2026